Citations

Clear

8 citation(s) found for "Link, Jenny L".

Retrospective Analysis of Longitudinal 3D Total Body Photography for Early Melanoma Detection
Phillipps, Jordan , Rios‐Duarte, Jorge A. , Tolaymat, Leila , Hardway, Heather , Comfere, Nneka I. , Youssef, Molly J. , Davis, Dawn Marie R. , Sominidi‐Damodaran, Sindhuja , Link, Jenny L. , Vidal, Nahid Y. , Barton, Christal, Meves, Alexander , Sartori‐Valinotti, Julio C. , Demer, Addison M.

Mayo Clinic

International Journal of Dermatology | November 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/ijd.70770 | PMID 42979691 Get It

Letter: Retrospective Review of Metals Patch Testing for Implantation of Cardiac Devices or Prosthetic Orthopedic Joints
Link, Phillip J. , Maniam, Ganesh B., Youssef, Molly J. , Davis, Mark DP., Link, Jenny L. , Maniam, Ganesh

Mayo Clinic

Dermatitis® | September 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/17103568261490392 | PMID 42741884 Get It

Expert consensus recommendations on appropriate treatment for telogen effluvium
Middleton, Hayden T. , Monahan, Erin, James, G, Franley, Brittney, Chavez, Magdalena, Kwong, Danny, Pham, Van, Griffith, Cynthia F. , Whinery, Sarah Jane, Blank, Alexander , Lightowler, Jennifer, Sledge, Eva, Griffith, Cynthia Faires , Link, Jenny

Mayo Clinic

Journal of Dermatology for Physician Assistants | August 21, 2026 | Volume: 20 | Issue: 3 | Pages: 8-13

10.1097/jdpa.0000000000000114 Get It

Background: Telogen effluvium (TE) is one of the most common forms of nonscarring alopecia. TE typically presents as sudden diffuse shedding of hair, and generally occurs 3–4 months after a triggering event such as physiological or psychological stress, certain medications, or hormonal changes. Despite the high prevalence of TE, no standardized clinical guidelines for the management of this condition currently exist. Objective: To address the lack of standard clinical guidelines for the management of TE, a multidisciplinary panel of dermatologists, dermatology advanced practice providers, and primary care providers convened to evaluate current evidence related to the treatment of TE. Methods: The primary research team, composed of 13 individuals, completed a comprehensive literature review of TE treatment. Then an expert panel conducted 2 rounds of article review, assessing each article based on the Strength of Recommendation Taxonomy (SORT) criteria and formulating consensus statements based on this data. An expert panel of 20 clinicians then evaluated the statements utilizing a structured eDelphi consensus process. Results: A total of 18 consensus statements regarding treatment recommendations for TE were reviewed by the expert panel. Of these, 3 statements addressed acute TE, while 15 focused on chronic TE. The panel evaluated each statement through open forum discussion, followed by voting and modification using the eDelphi methodology. Ultimately, 16 statements reached consensus following 2 rounds of the eDelphi survey. Conclusion: The self-limiting nature of acute TE warrants patient education, but no specific therapies were found to improve outcomes compared with placebo. While there is a gap in quality research regarding chronic TE treatment, current evidence suggests that topical minoxidil, vitamin D supplementation, and platelet-rich plasma may provide benefit in chronic TE based on individual clinical judgement.
Facial Discoid Dermatosis: Retrospective Clinical and Immunohistopathologic Cohort Study
Ziebart, Rachel, Newcomer, Jack B. , Chakraborty, Disha , Dacosta, A, Link, Jenny L. , Sominidi‐Damodaran, Sindhuja , Newcomer, Jack , Ziebart, Rachel L , Cull, Deborah B, Chakraborty, Disha , Lehman, Julia S , DaCosta, Adilson , Link, Jenny L , Sominidi Damodaran, Sindhuja , Cull, Deborah , Lehman, Julia S. , DaCosta, Adilson

Mayo Clinic

International Journal of Dermatology | May 23, 2026 | Volume: 65 | Issue: 9 | Pages: 1919-1922

10.1111/ijd.70505 | PMID 42175538 Get It

Oral Lichen Planus in Patients With Metal‐Containing Dental Hardware: A 13‐Year Observational Cohort Study
Hutson, Seneca D, Link, Jenny L. , Youssef, Molly J. , Link, Jenny L

Mayo Clinic

International Journal of Dermatology | April 11, 2026 | Volume: 65 | Issue: 9 | Pages: 1899-1900

10.1111/ijd.70433 | PMID 41964145 Get It

Expert consensus recommendations on appropriate serological testing for the chief complaint of alopecia
Middleton, Hayden T. , Monahan, Erin, James, Garland, Grippe, Kristen, Link, Jenny L. , Chavez, Magdalena, Sominidi‐Damodaran, Sindhuja , Pham, Van Trọng, Franley, Brittney, O’Brien, Jack C. , Whinery, Sarah Jane, James, Garland, Chavez, Magdalena, Pham, Van, Griffith, Cynthia Faires

Mayo Clinic

Journal of Dermatology for Physician Assistants | August 22, 2025 | Volume: 19 | Issue: 3 | Pages: 6-13

10.1097/jdpa.0000000000000067 Get It

Study Design: A panel of 13 clinicians with experience in dermatology and primary care was assembled to review literature regarding the diagnostic workup of scarring and nonscarring alopecias. The literature for review included clinical trials, meta-analyses, systematic reviews, and previously published guidelines from the last 10 years. After review, the panel drafted a list of consensus statements and then voted on these statements using a modified eDelphi method in order to verify the validity and clarity of each statement. Objective: Our objective, as a panel, was to formulate a clear set of guidelines in the workup of various forms of hair loss by a systematic review of clinical data and literature on the matter. Background: Hair loss is a common and frustrating medical concern for patients worldwide and accounts for significant health care utilization and cost. Moreover, hair loss may present as a symptom of an underlying medical condition requiring attention and treatment. Results: After review, the panel reached a total of 22 consensus statements regarding recommendations for diagnostic testing in the setting of hair loss, 17 of those statements focused on nonscarring alopecias, and 5 statements directed toward scarring alopecias. The statements were evaluated by members of the panel and voted on through a modified eDelphi method and discussed in an open forum. Conclusion: The panel’s review revealed that the diagnostic laboratories and/or scalp biopsy should be considered to varying degrees depending on the type of hair loss at presentation. If there is concern for a scarring process, a biopsy should be strongly considered, while serum laboratory work may be of little benefit. In nonscarring alopecias including alopecia areata, telogen effluvium, and androgenetic alopecia, the literature supports ordering certain serologic tests based on the type of hair loss at presentation.
Granulomatous tattoo reaction associated with BRAF/MEK inhibitor therapy for metastatic melanoma
Isaq, Nasro A., Jasmine, Sion W., Peters, Margot S. , Guo, Ruifeng , Link, Jenny L. , Link, Jenny L , Guo, Ruifeng , Markovic, Svetomir N.

Mayo Clinic

International Journal of Dermatology | May 31, 2024 | Volume: 63 | Issue: 11 | Pages: 1630-1632

10.1111/ijd.17273 | PMID 38816924 Get It

Iatrogenic Demodex folliculitis: A case report
Deo, Neha , Isaq, Nasro A., Peters, Margot S. , Link, Jenny L. , Link, Jenny, Deo, Neha N

Mayo Clinic

International Journal of Rheumatic Diseases | April 25, 2023 | Volume: 26 | Issue: 10 | Pages: 2073-2075

10.1111/1756-185x.14708 | PMID 37096969 Get It

AbstractDemodex folliculorum is a commensal mite that inhabits the orifices of cutaneous pilosebaceous follicles. Overgrowth of these organisms can lead to Demodex folliculitis, which typically presents as papules and pustules predominantly involving the temples, cheeks, and occasionally the chest. We present a 51‐year‐old woman with iatrogenic Demodex folliculitis secondary to immunosuppressive treatment for an autoimmune connective tissue disease. Histopathological exam of a skin biopsy, which revealed follicular Demodex mites, confirmed the diagnosis. The eruption was treated with oral ivermectin and topical metronidazole gel, and the patient's immunosuppressive regimen was decreased, resulting in marked improvement in the eruption within 6 weeks and no worsening of her underlying autoimmune disorder. This case emphasizes the importance of considering Demodex folliculitis in the differential diagnosis of a new onset rash in the context of immunosuppressive treatment.